Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Diana Abbott

Concepts (122)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Leukemia, Myeloid, Acute
7
2026
702
0.710
Why?
Bridged Bicyclo Compounds, Heterocyclic
7
2026
292
0.680
Why?
Plants, Edible
1
2019
8
0.590
Why?
Harm Reduction
1
2019
49
0.550
Why?
Sulfonamides
7
2026
594
0.510
Why?
Marijuana Smoking
1
2019
249
0.450
Why?
Wounds, Gunshot
1
2019
262
0.440
Why?
Cannabis
2
2019
521
0.430
Why?
Azacitidine
4
2026
168
0.370
Why?
Emergency Service, Hospital
3
2019
2363
0.360
Why?
Cord Blood Stem Cell Transplantation
2
2024
103
0.360
Why?
Firearms
1
2019
444
0.350
Why?
Hematopoietic Stem Cell Transplantation
3
2024
704
0.330
Why?
Antineoplastic Combined Chemotherapy Protocols
5
2026
1998
0.310
Why?
Graft vs Host Disease
3
2024
283
0.300
Why?
Laryngeal Neoplasms
2
2017
36
0.250
Why?
Transplantation Conditioning
2
2024
193
0.220
Why?
Transplantation, Haploidentical
1
2024
23
0.210
Why?
Lymphoma, Large B-Cell, Diffuse
1
2024
195
0.180
Why?
Multiple Myeloma
1
2023
310
0.150
Why?
Psychoses, Substance-Induced
1
2019
16
0.140
Why?
Lymphoma, Follicular
1
2019
57
0.140
Why?
Directive Counseling
1
2019
48
0.140
Why?
Cytochrome P-450 CYP2D6 Inhibitors
1
2018
4
0.140
Why?
Dextromethorphan
1
2018
24
0.140
Why?
Positron Emission Tomography Computed Tomography
1
2019
122
0.140
Why?
Cytochrome P-450 CYP2D6
1
2018
33
0.140
Why?
Pharmacogenomic Variants
1
2018
35
0.140
Why?
Vomiting
1
2019
131
0.140
Why?
Retrospective Studies
9
2024
17438
0.140
Why?
Neoplastic Stem Cells
2
2020
403
0.140
Why?
Oropharyngeal Neoplasms
1
2017
56
0.120
Why?
Marijuana Abuse
1
2019
217
0.120
Why?
Remission Induction
3
2026
308
0.120
Why?
Antineoplastic Agents
2
2026
2219
0.120
Why?
Acute Disease
1
2019
1038
0.120
Why?
Hodgkin Disease
1
2017
173
0.110
Why?
Programmed Cell Death 1 Receptor
1
2017
268
0.110
Why?
Middle Aged
10
2026
36619
0.110
Why?
Colorado
3
2019
4595
0.100
Why?
Antibodies, Monoclonal
2
2023
1512
0.100
Why?
Drug Resistance, Neoplasm
1
2020
893
0.100
Why?
Humans
20
2026
146342
0.100
Why?
Aged
10
2026
26432
0.090
Why?
Carcinoma, Squamous Cell
1
2017
628
0.090
Why?
Male
12
2026
73396
0.090
Why?
Neutrophils
1
2017
1133
0.080
Why?
Antibodies, Monoclonal, Humanized
1
2017
992
0.080
Why?
Female
12
2026
79499
0.080
Why?
Physicians
1
2019
955
0.080
Why?
Prognosis
3
2024
4351
0.070
Why?
Aged, 80 and over
4
2024
8391
0.060
Why?
Treatment Outcome
4
2026
11821
0.060
Why?
Adult
5
2024
41087
0.060
Why?
Cardiovascular Diseases
1
2019
2219
0.060
Why?
Stem Cells
2
2020
613
0.060
Why?
Socioeconomic Factors
2
2022
1327
0.050
Why?
Kaplan-Meier Estimate
2
2017
970
0.050
Why?
Etoposide
1
2024
169
0.050
Why?
Vincristine
1
2024
148
0.050
Why?
Cyclophosphamide
1
2024
275
0.050
Why?
ADP-ribosyl Cyclase 1
1
2023
43
0.050
Why?
Survival Analysis
2
2017
1378
0.050
Why?
Rituximab
1
2024
208
0.050
Why?
Prednisone
1
2024
229
0.050
Why?
Doxorubicin
1
2024
416
0.040
Why?
Time-to-Treatment
1
2024
257
0.040
Why?
ABO Blood-Group System
1
2022
56
0.040
Why?
Young Adult
3
2024
14330
0.040
Why?
Siblings
1
2022
202
0.040
Why?
Allografts
1
2021
151
0.040
Why?
Fetal Blood
1
2022
325
0.040
Why?
Niacinamide
1
2020
103
0.040
Why?
Tricarboxylic Acids
1
2018
11
0.040
Why?
Neoplasm, Residual
1
2019
143
0.040
Why?
Ketoglutaric Acids
1
2018
23
0.040
Why?
Medical Records
1
2019
193
0.040
Why?
Electron Transport Complex II
1
2018
27
0.040
Why?
Neoplasm Grading
1
2019
313
0.030
Why?
Succinate Dehydrogenase
1
2018
65
0.030
Why?
Substrate Specificity
1
2018
389
0.030
Why?
Oxidative Phosphorylation
1
2018
212
0.030
Why?
Proto-Oncogene Proteins c-bcl-2
1
2018
237
0.030
Why?
Fatty Acids
1
2020
460
0.030
Why?
Lymphocyte Count
1
2017
167
0.030
Why?
Glottis
1
2017
20
0.030
Why?
Drug Interactions
1
2018
405
0.030
Why?
Amino Acids
1
2020
515
0.030
Why?
Genetic Testing
1
2019
492
0.030
Why?
Salvage Therapy
1
2017
166
0.030
Why?
Transplantation, Homologous
1
2017
416
0.030
Why?
Administration, Oral
1
2018
872
0.030
Why?
Disease-Free Survival
1
2017
778
0.030
Why?
Lymphocytes
1
2017
379
0.030
Why?
Incidence
1
2022
2936
0.030
Why?
Insurance Coverage
1
2017
248
0.030
Why?
Propensity Score
1
2017
376
0.030
Why?
Patient Education as Topic
1
2019
770
0.030
Why?
Multivariate Analysis
1
2017
1543
0.020
Why?
Proportional Hazards Models
1
2017
1331
0.020
Why?
Genotype
1
2018
1879
0.020
Why?
Neoplasm Staging
1
2017
1488
0.020
Why?
Energy Metabolism
1
2018
930
0.020
Why?
Gene Expression
1
2017
1463
0.020
Why?
Logistic Models
1
2017
2126
0.020
Why?
Cell Differentiation
1
2019
1982
0.020
Why?
Databases, Factual
1
2017
1493
0.020
Why?
Models, Biological
1
2018
1761
0.020
Why?
Neoplasm Recurrence, Local
1
2017
1160
0.020
Why?
Apoptosis
1
2018
2439
0.020
Why?
Follow-Up Studies
1
2019
5439
0.020
Why?
Phenotype
1
2018
3206
0.020
Why?
Quality of Life
1
2022
3200
0.020
Why?
Cohort Studies
1
2019
6077
0.020
Why?
Risk Assessment
1
2018
3712
0.020
Why?
Health Services Accessibility
1
2017
1107
0.020
Why?
Surveys and Questionnaires
1
2019
6073
0.020
Why?
Time Factors
1
2017
7109
0.010
Why?
Prospective Studies
1
2018
8123
0.010
Why?
Adolescent
1
2024
22557
0.010
Why?
Child
1
2024
22693
0.010
Why?
United States
1
2017
16136
0.010
Why?
Abbott's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)